1-7 of 7
Kenneth Foon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials

Clinical Trials & Observations
Carla Casulo, Jesse G. Dixon, Jennifer Le-Rademacher, Eva Hoster, Howard S. Hochster, Wolfgang Hiddemann, Robert Marcus, Eva Kimby, Michael Herold, Catherine Sebban, Emmanuel Gyan, Kenneth Foon, Tina Nielsen, Umberto Vitolo, Gilles A. Salles, Qian Shi, Christopher R. Flowers
Journal: Blood
Blood (2022) 139 (11): 1684–1693.
https://doi.org/10.1182/blood.2020010263
Published: 2022
Includes: Supplemental data
Journal Articles

A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group

Caglar Caglayan, MS,PhD, Jesse Dixon, Statistician, MS, Anna Wall, Statistician, Gilles A. Salles, MD PhD, Eva Hoster, PhD, Wolfgang Hiddemann, MD PhD, Michael Herold, MD, Franck Morschhauser, MD PhD, Catherine Sebban, MD, Anton Hagenbeek, MD PhD, Robert Marcus, MD, Howard Hochster, MD, Mathias J Rummel, MD PhD, Eva Kimby, MD PhD, Umberto Vitolo, Bruce A. Peterson, MD, Emmanuel Gyan, MD PhD, Marco Ladetto, MD, Charles Yves Foussard, MD, Michele Ghielmini, MD, Tina G Nielsen, MD PhD, Kenneth Foon, MD, Qian Shi, PhD, Christopher R. Flowers, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2812.
https://doi.org/10.1182/blood-2019-122328
Published: 2019
Journal Articles

A Phase I/II Study of Reduced Dose FCR (FCR-lite) in Combination with Lenalidomide Followed By Lenalidomide Maintenance (FCR 2 ) for Initial Therapy of CLL: Final Results and Long-Term Follow-up

Anthony R. Mato, MD, Andre Goy, MD, Tatyana A Feldman, MD, Joanna Rhodes, MD, Lori A. Leslie, MD, Mary Mrkulic, BS, Sabrina Kdiry, BSN, Kara Yannotti, BSN, Marisa Valentinetti, BSN, Stephen J. Schuster, MD, Jakub Svoboda, MD, Kenneth Foon, MD, Alan P Skarbnik, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3012.
https://doi.org/10.1182/blood.V130.Suppl_1.3012.3012
Published: 2017
Journal Articles

Mechanisms of Suppression Used by Regulatory T Cells in Patients Newly Diagnosed with Acute Myeloid Leukemia

Miroslaw J Szczepanski, Marta Szajnik, Malgorzata Czystowska, Magis Mandapathil, Ann Welsh, Kenneth Foon, Theresa L Whiteside, Michael Boyiadzis
Journal: Blood
Blood (2008) 112 (11): 2938.
https://doi.org/10.1182/blood.V112.11.2938.2938
Published: 2008
Journal Articles

The Role of Interleukin-15 on Natural Killer Cell Homeostasis and Activity in Patients with Acute Myeloid Leukemia

Mi roslaw J Szczepanski, Malgorzata Czystowska, Marta E Szajnik, Magis Mandapathil, Benedict Hilldorfer, Ann Welsh, Kenneth Foon, Theresa L Whiteside, Michael Boyiadzis
Journal: Blood
Blood (2008) 112 (11): 2574.
https://doi.org/10.1182/blood.V112.11.2574.2574
Published: 2008
Journal Articles

Results of a Multi-Center, Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma (NHL).

Kenneth Foon, MD, Steven Allen, MD, Kaushik Sen, MD, Ann Mohrbacher, MD, Shamel Sanani, MD, Luigi Lenaz, MD, Rosamerlinda Rosales, MD
Journal: Blood
Blood (2005) 106 (11): 4741.
https://doi.org/10.1182/blood.V106.11.4741.4741
Published: 2005
Journal Articles

Modification of B-CLL Cells Via Infection with a Replication-Defective MVA Virus Encoding Three Costimulatory Molecules: A Potential Approach to Tumor Cell Immunotherapy of B-CLL.

Claudia Palena, Ph.D., Loni McIntosh, Jeffrey Schlom, Ph.D., Kenneth Foon, M.D., Dennis Panicali, Ph.D., Kwong Y. Tsang, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2516.
https://doi.org/10.1182/blood.V104.11.2516.2516
Published: 2004